Literature DB >> 9865836

Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi.

P Rudolph1, M Tronnier, R Menzel, M Möller, R Parwaresch.   

Abstract

To investigate the effect of ultraviolet (UV) irradiation on the expression of cell cycle-associated proteins, melanocytic nevi from healthy volunteers were partially covered, irradiated with a defined UV dose, and excised 1 week thereafter. The irradiated and the protected parts were examined separately by conventional microscopy and immunohistochemistry using the antibodies Ki-S11 (Ki-67), Ki-S7 (topoisomerase IIalpha), PC10 (proliferating cell nuclear antigen [PCNA]), DO-7 (p53), 6B6 (p21WAF1/Cip1), and the melanocytic marker HMB-45. DNA nick-end labeling was used as a marker of apoptosis. Irradiation resulted in morphological changes and increased HMB-45 reactivity. Proliferation, as assessed by Ki-67 and topoisomerase IIalpha expression, was also clearly enhanced in the UV-exposed areas. This was confirmed by the appearance of occasional mitotic figures. PCNA expression levels markedly exceeded those of the proliferation markers and did not correlate with the latter in most cases. p21 immunolabeling indices were also consistently augmented after UV exposure; hence it is likely that growth-inhibitory mechanisms partly compensate for the proliferative impulse, and the disproportional rise in PCNA expression probably reflects DNA repair activity. Enhanced p53 immunostaining in four cases suggests that the induction of p21 after irradiation may be p53 mediated, whereas no concomitant apoptotic events were observed. We conclude that UV light can stimulate the proliferative activity of melanocytes in melanocytic nevi, but that simultaneously cell cycle inhibitors are activated to permit DNA repair.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865836     DOI: 10.1016/s0046-8177(98)90019-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.

Authors:  W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

3.  Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

Authors:  P Rudolph; C Schubert; S Tamm; K Heidorn; A Hauschild; I Michalska; S Majewski; G Krupp; S Jablonska; R Parwaresch
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 4.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

Review 5.  Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression.

Authors:  Wei-Wen Sung; Chung-Hsing Chang
Journal:  Tzu Chi Med J       Date:  2021-07-16

6.  Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.

Authors:  Amaya Viros; Berta Sanchez-Laorden; Malin Pedersen; Simon J Furney; Joel Rae; Kate Hogan; Sarah Ejiama; Maria Romina Girotti; Martin Cook; Nathalie Dhomen; Richard Marais
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962

7.  Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.

Authors:  Rolando Ruiz-Vega; Chi-Fen Chen; Emaad Razzak; Priya Vasudeva; Tatiana B Krasieva; Jessica Shiu; Michael G Caldwell; Huaming Yan; John Lowengrub; Anand K Ganesan; Arthur D Lander
Journal:  Elife       Date:  2020-10-13       Impact factor: 8.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.